Skip to main content
. 2003 Apr;52(4):464–470. doi: 10.1136/gut.52.4.464

Figure 5.

Figure 5

Number of reflux episodes (A, C) and per cent time pH <4 (B, D) before and after four weeks of treatment with baclofen (10 gastro-oesophageal reflux disease (GORD) patients) (A, B) or placebo (six GORD patients) (C, D). Individual data for each patient and median and interquartile range are shown for the periods before and after four weeks of treatment with baclofen or placebo. ***p<0.001 versus basal.